Evidence map›Paper›PMID 39438130›Full record

ArticleInternational journal of cancer2025

RETRACTION: A Multiplicity of Anti-Invasive Effects of Farnesyl Transferase Inhibitor SCH66336 in Human Head and Neck Cancer.

Abstract readRetraction Notice
In one paragraph

Article in International journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

retractionS. H. Oh , J.-H. Kang , J. K. Woo , O.-H. Lee , E. S. Kim , and H.-Y. Lee , "A Multiplicity of Anti-Invasive Effects of Farnesyl Transferase Inhibitor SCH66336 in Human Head and Neck Cancer," International Journal of Cancer 131, no. 3 (2012): 537-547, https://doi.org/10.1002/ijc.26373. The above article, published online on 16 August 2011 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Prof. Christoph Plass; the Union for International Cancer Control; and John Wiley & Sons Ltd. Following publication, concerns were raised by third parties regarding Figure 2D. Additional concerns were found during an investigation by the editorial office regarding Figures 1A and 4A. The authors were unable to provide comprehensive original data. The retraction has been agreed because parts of the figures and the underlying data were duplicated. The editors no longer have confidence in the data reported in this article or in the interpretation of the results presented. The authors S. H. O, J.-H. K., and H.-Y. L. were informed of the decision to retract; J. K. W., O.-H. L., and E. S. K. could not be contacted.

Identifiers

PMID39438130
PMCPMC11577280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.